Cannabis & Autism
Patricia Frye, MD details how both core and coexisting conditions associated with Autistic Spectrum Disorder (ASD) may improve with cannabis medicine. The course also addresses the limitations of pharmaceuticals that are currently FDA approved for autism as well as those that are commonly used but based on anecdotal evidence. Dr. Frye reviews approaches to chemovar profiles, dosing regimens and special considerations when treating ASD in children and young adults.
*Includes a certificate of completion
The SCC provides continuing education for ourselves, patients, and colleagues about the medical use of cannabis and best practices in clinical care.
BECOME A MEMBER
Connect with healthcare professionals around the globe to get the most up-to-date medical cannabis information.